fda compounding semaglutide crackdown news november 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders Compound versions of GLP-1 drugs

We aimed to contrast addon therapy, adherence, and changes in biomarkers, 1 year after treatment initiation with GLP1 RA or metformin

There is a high degree of frustration when people are taking the time to administer medication and are not able to achieve the results they are expecting

TRIUMPH-4 studied obesity plus knee osteoarthritis without type 2 diabetes

Its critical for individuals to contact their insurance provider to discuss coverage details and potential out-of-pocket expenses

We gather hospital records and speak with treating physicians, as well as review scientific studies that connect GLP-1 drugs to long-term complications

[DOI] [PMC free article] [PubMed] [Google Scholar] 104.Kord Varkaneh H., Salehi Sahlabadi A., Gman M., et al